- Home
- ETB vs HRTX Comparison
ETB vs HRTX Comparison
Compare ETB & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETB
- HRTX
- Stock Information
- Founded
- ETB 2005
- HRTX 1983
- Country
- ETB United States
- HRTX United States
- Employees
- ETB N/A
- HRTX N/A
- Industry
- ETB Investment Bankers/Brokers/Service
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- ETB Finance
- HRTX Health Care
- Exchange
- ETB Nasdaq
- HRTX Nasdaq
- Market Cap
- ETB 363.4M
- HRTX 325.0M
- IPO Year
- ETB N/A
- HRTX 1987
- Fundamental
- Price
- ETB $14.54
- HRTX $1.91
- Analyst Decision
- ETB
- HRTX Strong Buy
- Analyst Count
- ETB 0
- HRTX 2
- Target Price
- ETB N/A
- HRTX $5.00
- AVG Volume (30 Days)
- ETB 71.8K
- HRTX 1.4M
- Earning Date
- ETB 01-01-0001
- HRTX 08-05-2025
- Dividend Yield
- ETB 8.23%
- HRTX N/A
- EPS Growth
- ETB N/A
- HRTX N/A
- EPS
- ETB N/A
- HRTX N/A
- Revenue
- ETB N/A
- HRTX $148,518,000.00
- Revenue This Year
- ETB N/A
- HRTX $12.08
- Revenue Next Year
- ETB N/A
- HRTX $12.57
- P/E Ratio
- ETB N/A
- HRTX N/A
- Revenue Growth
- ETB N/A
- HRTX 12.43
- 52 Week Low
- ETB $11.59
- HRTX $1.04
- 52 Week High
- ETB $14.08
- HRTX $3.22
- Technical
- Relative Strength Index (RSI)
- ETB 61.24
- HRTX 39.19
- Support Level
- ETB $14.25
- HRTX $1.87
- Resistance Level
- ETB $14.51
- HRTX $1.98
- Average True Range (ATR)
- ETB 0.12
- HRTX 0.08
- MACD
- ETB -0.02
- HRTX -0.03
- Stochastic Oscillator
- ETB 82.86
- HRTX 9.76
About ETB Eaton Vance Tax-Managed Buy-Write Income Fund Eaton Vance Tax-Managed Buy-Write Income Fund of Beneficial Interest
Eaton Vance Tax-Managed Buy-Write Income Fund is a United States-based diversified closed ended management investment company. The fund's investment objective is to provide current income and gains, with a secondary objective of capital appreciation. It invests in a diversified portfolio of common stocks and writes call options on one or more U.S. indices on a substantial portion of the value of its common stock portfolio to generate current earnings from the option premium. Its portfolio of investments consists of aerospace and defense, banks, biotechnology, chemicals, consumer finance, industrial conglomerates, and others.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.